fda glp-1 compounding warning october 2025 letters news Issues 30 to Telehealth Firms Over Misleading Compounded Marketing FDA Issues Warning Letters to – FDA Targets Telehealth Compounded GLP-1

Mice with RyR1 mutation (Y524S) undergo hypermetabolic response to simvastatin

Restoring the normal response of mitophagy plays a protective role against the pathogenesis of neurodegenerative diseases

A handful of studies have found that GLP-1 receptor agonist drugs alter how your body and mind process flavor

Recalls & Warnings October 09, 2023 Organifi Settles Charges of Unsupported Claims Organifi, LLC has agreed to pay $150,000 in civil penalties and $50,000 in investigative costs as restitution to settle charges that the company made unsupported claims that its Gold, Pure, Green Juice, and Red Juice products could balance hormone and cortisol levels, regulate the